Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

SAN DIEGO — While psoriasis is linked to higher rates of dementia, a new study suggested that older patients with psoriasis on systemic treatments may have a much lower risk than those not ...

Researchers conducted a phase 3b randomized study of a cohort in the VISIBLE trial, which included 103 adults with skin of color and moderate-to-severe psoriasis (mean age, 44.1 years; 28.2% women ...

To evaluate this, the authors systematically reviewed 14 studies involving a total of 169 patients (mean age 46.8 years), 74% of whom were women. The majority underwent gastric bypass surgery (75.1%), ...

A recently published analysis that appeared in the Journal of American Academy of Dermatology has concluded that the general percentage of adults in ...

The company said that the trials (double-blind, placebo-controlled Phase 2 trial evaluated the efficacy and safety) were conducted in 263 patients with moderate to severe plaque psoriasis.

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a preclinical-stage, oral drug for psoriasis. US-based Nimble was set up in ...

Turmeric and ginger are antioxidant powerhouses—but which is stronger? Discover benefits, side effects, and whether you can ...

Magnesium oil applied to the feet may have some beneficial effects for certain health issues, including psoriasis and foot ...

Soligenix (NASDAQ: SNGX) is at the forefront of the effort as the medical community urgently seeks alternative treatments for bacterial infections i ...

Cannabidiol (CBD) may be beneficial in treating pain and inflammation. Learn more about how to use CBD for inflammation and what products to try here.